menu
    • menu

    Company profile for CytoSen Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cyto-Sen Therapeutics, Inc., a biopharmaceutical company, develops natural killer cells with its particle-based expansion and activation process to treat cancer. It produces cellular immunotherapeutics to treat cancers through personalized and universal donor sources. Cyto-Sen Therapeutics, Inc. has a strategic partnership with KBI Biopharma. The company was founded in 2014 and is based in Orlando, Florida. As of June 6, 2019,...
    Cyto-Sen Therapeutics, Inc., a biopharmaceutical company, develops natural killer cells with its particle-based expansion and activation process to treat cancer. It produces cellular immunotherapeutics to treat cancers through personalized and universal donor sources. Cyto-Sen Therapeutics, Inc. has a strategic partnership with KBI Biopharma. The company was founded in 2014 and is based in Orlando, Florida. As of June 6, 2019, Cyto-Sen Therapeutics, Inc. operates as a subsidiary of Kiadis Pharma N.V.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytoSen TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3259 Progress Drive Orlando, FL 32826
    Telephone
    Telephone
    510-407-5383
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.cytosen.com
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cyto-sen-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CytoSenTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kiadis abandons lead PhIII program, shifts focus to natural killer cells
    Kiadis abandons lead PhIII program, shifts focus to natural killer cells

    12 Nov 2019

    // Jason Mast ENDPTS

    https://endpts.com/kiadis-kills-its-lead-phiii-program-shifts-focus-to-natural-killer-cells/

    Jason Mast ENDPTS
    12 Nov 2019
    Share Share
    Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.
    Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.

    05 Jun 2019

    // BIOSPACE

    https://www.biospace.com/article/kiadis-pharma-completes-acquisition-of-cytosen-therapeutics-inc-/?s=79

    BIOSPACE
    05 Jun 2019
    Share Share
    Stem cell transplant firms Kiadis and CytoSen join forces
    Stem cell transplant firms Kiadis and CytoSen join forces

    18 Apr 2019

    // Amber Tong ENDPTS

    https://endpts.com/t-cell-experts-at-kiadis-bag-cytosens-nk-cell-tech-plotting-a-dual-cancer-killing-approach-with-tips-from-carl-june/

    Amber Tong ENDPTS
    18 Apr 2019
    Share Share
    Kiadis to buy CytoSen, adding June to advisory board
    Kiadis to buy CytoSen, adding June to advisory board

    17 Apr 2019

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kiadis-to-buy-cytosen-adding-carl-june-to-advisory-board

    Nick Paul Taylor FIERCE BIOTECH
    17 Apr 2019
    Share Share
    CytoSen Thera's Receives FDA’s Favorable Response to Pre-IND Meeting for AML
    CytoSen Thera's Receives FDA’s Favorable Response to Pre-IND Meeting for AML

    27 Sep 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180927005156/en/CytoSen-Therapeutics-Receives-FDA%E2%80%99s-Favorable-Response-Pre-IND

    BUSINESSWIRE
    27 Sep 2018
    Share Share
    CytoSen Receives FDA’s Response to Pre-IND Meeting for Ph 2 Study in AML
    CytoSen Receives FDA’s Response to Pre-IND Meeting for Ph 2 Study in AML

    27 Sep 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180927005156/en

    BUSINESSWIRE
    27 Sep 2018
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search